Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Eli Lilly reduces price of weight loss medicine Zepbound, offering discounts to patients. Obesity rates skyrocket in America.

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab ...

The world’s first trillionaire woman will (by current projections) by Francoise Bettencourt Meyers, granddaughter of the ...

Eli Lilly will now sell cheaper vials of Zepbound ... “There is no reason why any single U.S. person should be on a non-F.D.A. approved medicine that is not controlled for safety, quality ...